<DOC>
	<DOCNO>NCT01543126</DOCNO>
	<brief_summary>Change IL-6 IL-8 level blood pleural effusion chemotherapy correlate prognosis disease</brief_summary>
	<brief_title>IL-6 IL-8 Level Blood Pleural Effusion During Chemotherapy Metastatic Breast Cancer</brief_title>
	<detailed_description>To assess correlation disease prognosis level IL-6 IL-8 blood pleural effusion chemotherapy patient metastatic breast cancer</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Pleural Effusion</mesh_term>
	<criteria>Female 18 70 year old ; Patients histologic prove metastatic breast cancer ; Pleural effusion volume 1000ml , document CT , X ray ultrasound ; There diseases cause elevation IL6 IL8 , cirrhosis liver , anaphylactoid purpura , acute pancreatitis ; With least one measurable disease accord RECIST criterion , Normal laboratory result : ANC≥2.0×109/L , Hb≥80g/L , plt≥100×109/L , TB &lt; UNL ( &lt; 1.5 x UNL patient liver mets ) , ALT/AST &lt; 1.5 x UNL ( &lt; 2.5x UNL patient liver mets ) , AKP &lt; 5 x UNL ( except bone mets ) , Cr &lt; UNL ; Normal function heart , liver , renal bone marrow ; Got ICF enrollment ; Life expectancy 12 week . Pregnant breastfeed woman positive serum pregnancy test ; Uncontrolled brain metastasis ; No recovery previous radiation accept radiation within 4 week enrollment ; Participation investigational drug study within 4 week precede treatment start ; Concurrent malignancy sit previous cancer within last 5 year , exception adequately treat situ carcinoma cervix uteri basal squamous cell carcinoma skin ; Serious uncontrolled intercurrent infection ; Poor compliance .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>